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CASE
A46-year-old man with a history of diabetes mellitus (type I), hypertension, conges-tive heart failure, and coronary artery disease presented to his primary care
physician with a 3-week history of ulceration on his left, great toe. The patient reported
poor compliance with blood glucose level checks and insulin use. Upon examination,
the physician noted a 1- by 1.5-cm ulcer on the underside of the patient’s toe. The ulcer
was debrided, and a specimen for microbiological culture was collected on a ﬂocked
swab. As part of this routine work-up, the physician took a detailed history and noted
that the patient lived alone with his two dogs.
A specimen Gram stain revealed no polymorphonuclear leukocytes but abundant
Gram-positive cocci. The specimen was plated to sheep blood agar (SBA), chocolate
agar, and MacConkey agar. The next day, abundant white beta-hemolytic colonies
resembling Staphylococcus spp. were noted on the blood agar plate (BAP) and white
colonies were noted on the chocolate plate. No other organisms grew in this culture.
No growth was observed on the MacConkey agar plate. Upon further testing, the
isolate was positive for catalase, coagulase (StaphTEX Blue; Hardy Diagnostics, Santa
Maria, CA), and pyrrolidonyl arylamidase (PYR [Oxoid biochemical identiﬁcation
system]; Thermo Scientiﬁc, Hampshire, United Kingdom). A rapid immunochromato-
graphic assay for penicillin-binding protein 2a was positive (PBP2a culture colony test;
Alere Inc., Waltham, MA). The isolate was identiﬁed by matrix-assisted laser desorption–
ionization time of ﬂight (MALDI-TOF) mass spectrometry (MS) as Staphylococcus inter-
medius, a member of the S. intermedius group (SIG), with a score of 2.022. Susceptibility
testing was notable for discrepant results for methicillin resistance testing by Kirby-
Bauer disk diffusion: the isolate was oxacillin resistant (zone size of 17 mm) and cefoxitin
susceptible (zone size of 35 mm). Otherwise, the isolate exhibited intermediate resistance
to trimethoprim-sulfamethoxazole and was susceptible to vancomycin, linezolid, doxycy-
cline, clindamycin, and erythromycin, as per Clinical and Laboratory Standards Institute
document M100 (1). The patient was treated empirically with oral doxycycline and
topical gentamicin cream and recovered well.
DISCUSSION
Members of the Staphylococcus intermedius group (SIG) include S. intermedius, S.
pseudintermedius, and S. delphini. SIG members are common colonizers of animal
mucosal surfaces, especially those of dogs (2, 3). Though it can be a component of the
normal ﬂora of the mouth, nose, and skin, the SIG, particularly S. pseudintermedius, has
been implicated as a common cause of pyoderma in dogs (4, 5). In studies assessing
carriage rates among dogs and cats, S. pseudintermedius was found to colonize up to
68% of dogs and up to 22% of cats, whereas S. aureus was a colonizer of up to 14% of
dogs and 20% of cats (2). Other species of animal-adapted staphylococci include S.
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schleiferi (canine), S. felis (feline), S. lutrae, S. hyicus (porcine, coagulase variable), and S.
agnetis (bovine, coagulase variable).
Members of SIG were recently separated into individual species, with the most
recent taxonomic change occurring in 2005 with the creation of the S. pseudintermedius
species (4). Staphylococcus delphini, originally isolated from a dolphin specimen, is
associated with many types of animals, including birds, cats, horses, and other
mammals (4). Despite taxonomic differences, the members of this group are difﬁcult
to differentiate phenotypically, suggesting that these species may be interchange-
ably misidentiﬁed (4).
In humans, SIG infections are increasingly recognized. Prior to the advent of
MALDI-TOF MS for the identiﬁcation of bacterial isolates from clinical specimens, SIG
members were thought to uncommonly infect humans and were generally associated
with dog bites (3–5), foreign-body-related infections, food poisoning, and invasive
infections in immunocompromised patients (4). In one study of 39 patients with SIG
infections, only 4 had a history of contact with a dog, 2 of which had a SIG member
isolated from a dog bite (3). Additionally, SIG isolates were recovered from specimens,
including wounds, ears, diabetic ulcers, and cutaneous ulcers (3). In other reports, the
SIG was implicated in various other infections, including infective endocarditis and
hardware/device infections (6). Differentiating infection from colonization when treat-
ing patients with a SIG member can be difﬁcult. For example, the primary-specimen
Gram stain of this case showed no polymorphonuclear leukocytes but abundant Gram-
positive cocci, suggesting colonization with a SIG member since no inﬂammatory cells
were present. However, this patient was treated because, clinically, this looked like an
infection and the swab specimen from this open ulcer grew abundant SIG bacteria.
SIG species are very similar to S. aureus in both clinical presentation and microbi-
ologic characteristics, including coagulase positivity, and it is likely that SIG isolates
from human clinical specimens were identiﬁed as S. aureus prior to MALDI-TOF MS (6).
Historically, coagulase-positive staphylococci isolated from veterinary specimens were
identiﬁed as SIG, whereas these isolates were identiﬁed as S. aureus in human speci-
mens (5). Very few systematic studies have been conducted to evaluate the ability of
MALDI-TOF MS instruments to identify SIG isolates. In one study using the Vitek MS
(bioMérieux, Durham, NC), four SIG isolates were tested, resulting in three isolates of S.
intermedius identiﬁed to the genus level and one isolate of S. pseudintermedius iden-
tiﬁed to the species level (no MALDI-TOF database was speciﬁed in the publication). No
S. delphini isolates were tested (7). In contrast to that of the Vitek MS, the performance
of the Biotyper MALDI-TOF MS in identifying members of the SIG has been more
rigorously evaluated. In a study focused on identiﬁcation of human SIG isolates with the
Bruker Biotyper MALDI-TOF MS (database version 3.0), all SIG isolates achieved a score
of 1.7 (genus-level identiﬁcation), and 78.9% (15/19) of the S. delphini isolates, 76.5%
(13/17) of the S. intermedius isolates, and 89.5% (145/162) of the S. pseudintermedius
isolates achieved a score of 2.0 (species-level identiﬁcation) (8).
Like S. aureus, SIG species are catalase positive, coagulase positive, Gram-positive
cocci in clusters (Table 1). Like S. aureus, SIG isolates may grow on mannitol salt agar,
TABLE 1 Biochemical characteristics used to differentiate Staphylococcus aureus from animal-adapted, coagulase-positive Staphylococcus
speciesa
Staphylococcus species











S. aureus    V   
S. intermedius V     V 
S. pseudintermedius       V
S. delphini   ND    
S. schleiferi subsp. schleiferi       
S. schleiferi subsp. coagulans   V   V 
aData are adapted from references 4 and 11. , 90% or more strains were positive; V, results were varied; , 90% or more strains were negative; ND, not determined.
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which is often used in S. aureus colonization screening cultures, and many will ferment
D-mannitol (Table 1), producing a yellow colony that might be suggestive of S. aureus
(Fig. 1F) (4). However, colonies of SIG isolates can be whiter than S. aureus on SBA plates
(Fig. 1A and C). Additionally, SIG isolates are beta-hemolytic, with a double zone of
hemolysis (see the clearing and darkening of the agar in Fig. 1D), compared to S. aureus,
FIG 1 Colony morphologies of Staphylococcus intermedius group members and Staphylococcus aureus at 24
h of growth. (A) Colony morphology of S. aureus on a sheep blood agar plate. (B) Beta-hemolysis caused
by S. aureus. The photo was taken using backlighting to highlight the hemolysis pattern. (C) Colony
morphology of S. intermedius group on a sheep blood agar plate. (D) Double zone of beta-hemolysis caused
by an S. intermedius group member. The photo was taken using backlighting to highlight the hemolysis
pattern. (E) Growth of an S. intermedius group member on a Spectra MRSA chromogenic agar plate (Remel
Microbiology Products, Lenexa, KS). (F) Growth of an S. intermedius group member on mannitol salt agar
(Remel Microbiology Products).
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which has a single zone of beta-hemolysis (Fig. 1B). Despite both being coagulase
positive (4), SIG isolates exhibit a slightly different result from S. aureus isolates in latex
agglutination testing (i.e., see the more chunky and stringy clumping in Fig. 2A and B),
and instances of coagulase-positive S. pseudintermedius misidentiﬁcation due to neg-
ative latex agglutination tests have been documented (4). This misidentiﬁcation can
happen because current Staphylococcus latex agglutination tests employ antibodies to
clumping factor and staphylococcal protein A (product of the spa gene) (4). Whereas
all SIG species are coagulase positive, only S. intermedius has been shown to have
clumping factor (Table 1). Regardless of similar morphologies and characteristics, SIG
members and S. aureus can be efﬁciently differentiated using a variety of biochemical
tests (Table 1), including the PYR test (S. aureus negative, SIG positive) (Fig. 2C) (4).
Until the early 2000s, very little methicillin resistance (5% of isolates) was observed
in veterinary SIG isolates, but methicillin resistance in SIG members is on the rise (9). As
in S. aureus, methicillin resistance in SIG species is conferred by alternative penicillin
binding proteins (PBPs) through the acquisition of the mecA gene, which encodes
PBP2a (10). Unlike in S. aureus and the coagulase-negative staphylococci, cefoxitin has
proven to be a poor surrogate indicator of methicillin resistance in SIG isolates;
compared to the presence of mecA as determined by PCR, the use of cefoxitin as a
surrogate indicator of methicillin resistance resulted in both major and very major
errors (5). Rather, oxacillin is the appropriate surrogate for methicillin resistance in SIG
isolates (Fig. 2D) (5, 10). Oxacillin susceptibility breakpoints for SIG members have been
added to CLSI supplement M100 for this purpose (1). It is recognized that this testing
can be problematic for some clinical laboratories, since automated identiﬁcation and
susceptibility systems (such as the BD Phoenix and bioMérieux Vitek 2 systems) may not
routinely report an oxacillin MIC result (5) and since some clinical laboratories do not
use oxacillin for antimicrobial susceptibility testing. For this reason, immunochromato-
graphic testing for the presence of PBP2a has been studied in SIG isolates and was
shown to have 100% sensitivity and 100% speciﬁcity for the detection of methicillin
resistance in a comparison withmecA PCR (10), particularly when induced PBP2a testing
with cefoxitin was used (5). Isolates of the SIG can also grow on chromogenic media for
the detection of methicillin-resistant S. aureus (MRSA), such as Spectra MRSA agar
(Remel Microbiology Products, Lenexa, KS). While SIG isolates do not produce the
characteristic “denim blue” colony color of MRSA on these plates (Fig. 1E), the
colonies may be considered suspicious for MRSA.
FIG 2 Biochemical characteristics of Staphylococcus intermedius group members compared to those of
Staphylococcus aureus, and susceptibility testing for S. intermedius group members. (A) Latex agglutina-
tion test (coagulase) result for S. aureus; (B) latex agglutination test (coagulase) result for S. intermedius
group members; (C) PYR testing results for S. aureus (left, negative) and S. intermedius group members
(right, positive); (D) discrepant cefoxitin (FOX 30; 26-mm diameter) and oxacillin (OX 1; 15-mm diameter)
results for an S. intermedius group isolate.
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Members of the SIG are human pathogens that may be misidentiﬁed when we rely
on biochemical tests such as coagulase and latex agglutination for identiﬁcation of
catalase-positive, Gram-positive cocci. Accurate identiﬁcation has important implica-
tions for the interpretation of disk diffusion susceptibility testing, including the deter-
mination of methicillin resistance. However, identiﬁcation using MALDI-TOF MS is
reliable for identifying these isolates as members of the SIG.
SELF-ASSESSMENT QUESTIONS
1. Which biochemical test can be helpful as a screen to differentiate SIG species
from Staphylococcus aureus?
A. Catalase
B. Pyrrolidonyl arylamidase (PYR)
C. Coagulase
D. Ornithine decarboxylase
2. Disk diffusion testing with which antimicrobial agent should be tested as a
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